METTL3 (Methyltransferase Like 3)-Dependent N6-Methyladenosine Modification on Braf mRNA Promotes Macrophage Inflammatory Response and Atherosclerosis in Mice
Arteriosclerosis, Thrombosis, and Vascular Biology · 2023-05 · 43 (5) · 755-773
DOI: 10.1161/atvbaha.122.318451 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2023-05. Verfasst von Qian Li und 19 weiteren Autor:innen. Beteiligte Einrichtung: The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese National Health Commission and Chinese …. Hauptthemen laut MEDLINE: Plaque, Atherosclerotic, Atherosclerosis. Die Arbeit wurde bisher 77-mal zitiert (Crossref) und nennt 51 Literaturangaben.
Abstract (Originalsprache)
Background
Atherosclerosis is a chronic inflammatory disease, in which macrophages determine the progression of atherosclerotic plaques. However, no studies have investigated how METTL3 (methyltransferase like 3) in macrophages affects atherosclerotic plaque formation in vivo. Additionally, whether Braf mRNA is modified by METTL3-dependent N6-methyladenosine (m6A) methylation remains unknown.
Methods
We analyzed single-cell sequencing data of atherosclerotic plaques in mice fed with a high fat diet for different periods. Mettl3 fl/fl Lyz 2 cre Apoe –/– mice and littermate control Mettl3 fl/fl Apoe –/– mice were generated and fed high fat diet for 14 weeks. In vitro, we stimulated peritoneal macrophages with ox-LDL (oxidized low-density lipoprotein) and tested the mRNA and protein expression levels of inflammatory factors and molecules regulating ERK (extracellular signal-regulated kinase) phosphorylation. To find METTL3 targets in macrophages, we performed m6A-methylated RNA immunoprecipitation sequencing and m6A-methylated RNA immunoprecipitation-qPCR. Further, point mutation experiments were used to explore m6A-methylated adenine. Using RNA immunoprecipitation assay, we explored m6A methylation-writing protein bound to Braf mRNA.
Results
In vivo, METTL3 expression in macrophages increased with the progression of atherosclerosis. Myeloid cell–specific METTL3 deletion negatively regulated atherosclerosis progression and the inflammatory response. In vitro, METTL3 knockdown or knockout in macrophages attenuated ox-LDL-mediated ERK phosphorylation rather than JNK (c-Jun N-terminal kinase) and p38 phosphorylation and reduced the level of inflammatory factors by affecting BRAF protein expression. The negative regulation of inflammation response caused by METTL3 knockout was rescued by overexpression of BRAF. In mechanism, METTL3 targeted adenine (39725126 in chromosome 6) on the Braf mRNA. Then, YTHDF1 could bind to m6A-methylated Braf mRNA and promoted its translation.
Conclusions
Myeloid cell–specific Mettl3 deficiency suppressed hyperlipidemia-induced atherosclerotic plaque formation and attenuated atherosclerotic inflammation. We identified Braf mRNA as a novel target of METTL3 in the activation of the ox-LDL-induced ERK pathway and inflammatory response in macrophages. METTL3 may represent a potential target for the treatment of atherosclerosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese National Health Commission and Chinese Academy of Medical Sciences, The State and Shandong Province Joint Key…
- Cardiovascular Disease Research Center, Jinan Central Hospital, Shandong First Medical University, China (X.G., G.S., Y.Z., M.Z., C.Z.).
- Key Laboratory Experimental Teratology of the Ministry of Education, Department of Physiology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, China (X.Y.).
- Department of Epidemiology, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China (B.X.).
ORCID-Profile: Qian Li, Liwen Yu, Xiao Yu, Bo Xi, Yun Zhang, Meng Zhang, Cheng Zhang
Zitieren
APA
Li, Q., Yu, L., Gao, A., Ren, R., Zhang, J., Cao, L., Wang, X., Liu, Y., Qi, W., Cai, L., Li, W., Wang, W., Guo, X., Su, G., Yu, X., Zhang, J., Xi, B., Zhang, Y., Zhang, M., & Zhang, C. (2023). METTL3 (Methyltransferase Like 3)-Dependent N6-Methyladenosine Modification on Braf mRNA Promotes Macrophage Inflammatory Response and Atherosclerosis in Mice. Arteriosclerosis, Thrombosis, and Vascular Biology, 43(5), 755-773. https://doi.org/10.1161/atvbaha.122.318451
Vancouver
Li Q, Yu L, Gao A, Ren R, Zhang J, Cao L, et al. METTL3 (Methyltransferase Like 3)-Dependent N6-Methyladenosine Modification on Braf mRNA Promotes Macrophage Inflammatory Response and Atherosclerosis in Mice. Arteriosclerosis, Thrombosis, and Vascular Biology. 2023;43(5):755-773. doi:10.1161/atvbaha.122.318451
BibTeX
@article{Li2023,
author = {Li, Qian and Yu, Liwen and Gao, Amy and Ren, Ruiqing and Zhang, Jianlin and Cao, Lei and Wang, Xiaohong and Liu, Yapeng and Qi, Wenqian and Cai, Liangyu and Li, Wei and Wang, Weiwei and Guo, Xiaobin and Su, Guohai and Yu, Xiao and Zhang, Jie and Xi, Bo and Zhang, Yun and Zhang, Meng and Zhang, Cheng},
title = {METTL3 (Methyltransferase Like 3)-Dependent N6-Methyladenosine Modification on Braf mRNA Promotes Macrophage Inflammatory Response and Atherosclerosis in Mice},
journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
year = {2023},
volume = {43},
number = {5},
pages = {755--773},
doi = {10.1161/atvbaha.122.318451}
}
EUVIMED